Georgios Drakakis

Georgios Drakakis

Auto-generated profile, based on publicly available information

Georgios Drakakis

School of Chemical Engineering, National Technical University of Athens, Zografou Campus, 9 Heroon Polytechniou Street, 15780 Athens, Greece

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2015 in Journal of Cheminformatics
Verified
Journal Article
Open access
PDF file
LMLewis H. Mervin
Lewis H. Mervin
AAAvid M. Afzal
Avid M. Afzal
GDGeorgios Drakakis
Georgios Drakakis
RLRichard Lewis
Richard Lewis
OEOla Engkvist
Ola Engkvist
ABAndreas Bender
Andreas Bender
In silico analyses are increasingly being used to support mode-of-action investigations; however many such approaches do not utilise the large amounts of inactive data held in chemogenomic repositories. The objective of this work is concerned with the integration of such bioactivity data in the target prediction of orphan compounds to produce the probability of activity and inactivity for a range of targets. To this end, a novel human bioactivity data set was constructed through the assimilation of over 195 million bioactivity data points deposited in the ChEMBL and PubChem repositories, and the subsequent application of a sphere-exclusion selection algorithm to oversample presumed inactive compounds. A Bernoulli Naïve Bayes algorithm was trained using the data and evaluated using fivefold cross-validation, achieving a mean recall and precision of 67.7 and 63.8 % for active compounds and 99.6 and 99.7 % for inactive compounds, respectively. We show the performances of the models are considerably influenced by the underlying intraclass training similarity, the size of a given class of compounds, and the degree of additional oversampling. The method was also validated using compounds extracted from WOMBAT producing average precision-recall AUC and BEDROC scores of 0.56 and 0.85, respectively. Inactive data points used for this test are based on presumed inactivity, producing an approximated indication of the true extrapolative ability of the models. A distance-based applicability domain analysis was also conducted; indicating an average Tanimoto Coefficient distance of 0.3 or greater between a test and training set can be used to give a global measure of confidence in model predictions. A final comparison to a method trained solely on active data from ChEMBL performed with precision-recall AUC and BEDROC scores of 0.45 and 0.76. The inclusion of inactive data for model training produces models with superior AUC and improved early recognition capabilities, although the results from internal and external validation of the models show differing performance between the breadth of models. The realised target prediction protocol is available at https://github.com/lhm30/PIDGIN .

16 September 2014 in Molecular BioSystems
Verified
Journal Article
Open access
PDF file
ARAakash Chavan Ravindranath
Aakash Chavan Ravindranath
NPNolen Perualila-Tan
Nolen Perualila-Tan
AKAdetayo Kasim
Adetayo Kasim
GDGeorgios Drakakis
Georgios Drakakis
SLSonia Liggi
Sonia Liggi
ABAndreas Bender
Andreas Bender
Integrating gene expression profiles with certain proteins can improve our understanding of the fundamental mechanisms in protein–ligand binding. This paper spotlights the integration of gene expression data and target prediction scores, providing insight into mechanism of action (MoA). Compounds are clustered based upon the similarity of their predicted protein targets and each cluster is linked to gene sets using Linear Models for Microarray Data. MLP analysis is used to generate gene sets based upon their biological processes and a qualitative search is performed on the homogeneous target-based compound clusters to identify pathways. Genes and proteins were linked through pathways for 6 of the 8 MCF7 and 6 of the 11 PC3 clusters. Three compound clusters are studied; (i) the target-driven cluster involving HSP90 inhibitors, geldanamycin and tanespimycin induces differential expression for HSP90-related genes and overlap with pathway response to unfolded protein. Gene expression results are in agreement with target prediction and pathway annotations add information to enable understanding of MoA. (ii) The antipsychotic cluster shows differential expression for genes LDLR and INSIG-1 and is predicted to target CYP2D6. Pathway steroid metabolic process links the protein and respective genes, hypothesizing the MoA for antipsychotics. A sub-cluster (verepamil and dexverepamil), although sharing similar protein targets with the antipsychotic drug cluster, has a lower intensity of expression profile on related genes, indicating that this method distinguishes close sub-clusters and suggests differences in their MoA. Lastly, (iii) the thiazolidinediones drug cluster predicted peroxisome proliferator activated receptor (PPAR) PPAR-alpha, PPAR-gamma, acyl CoA desaturase and significant differential expression of genes ANGPTL4, FABP4 and PRKCD. The targets and genes are linked via PPAR signalling pathway and induction of apoptosis, generating a hypothesis for the MoA of thiazolidinediones. Our analysis show one or more underlying MoA for compounds and were well-substantiated with literature.

22 December 2014 in Future Medicinal Chemistry
Verified
Journal Article
Closed access
SLSonia Liggi
Sonia Liggi
GDGeorgios Drakakis
Georgios Drakakis
AKAlexios Koutsoukas
Alexios Koutsoukas
ICIsidro Cortes–Ciriano
Isidro Cortes–Ciriano
PMPatricia Martínez–Alonso
Patricia Martínez–Alonso
ABAndreas Bender
Andreas Bender
Background: An in silico mechanism-of-action analysis protocol was developed, comprising molecule bioactivity profiling, annotation of predicted targets with pathways and calculation of enrichment factors to highlight targets and pathways more likely to be implicated in the studied phenotype. Results: The method was applied to a cytotoxicity phenotypic endpoint, with enriched targets/pathways found to be statistically significant when compared with 100 random datasets. Application on a smaller apoptotic set (10 molecules) did not allowed to obtain statistically relevant results, suggesting that the protocol requires modification such as analysis of the most frequently predicted targets/annotated pathways. Conclusion: Pathway annotations improved the mechanism-of-action information gained by target prediction alone, allowing a better interpretation of the predictions and providing better mapping of targets onto pathways.

6 May 2013 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
PDF file
HNHa P. Nguyen
Ha P. Nguyen
AKAlexios Koutsoukas
Alexios Koutsoukas
FFFazlin Mohd Fauzi
Fazlin Mohd Fauzi
GDGeorgios Drakakis
Georgios Drakakis
MMMateusz Maciejewski
Mateusz Maciejewski
ABAndreas Bender
Andreas Bender

18 October 2013 in Molecular Informatics
Verified
Journal Article
Closed access
PDF file
SLSonia Liggi
Sonia Liggi
GDGeorgios Drakakis
Georgios Drakakis
AHAdam E. Hendry
Adam E. Hendry
KHKimberley M. Hanson
Kimberley M. Hanson
SBSuzanne C. Brewerton
Suzanne C. Brewerton
ABAndreas Bender
Andreas Bender

1 January 2016 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
SZSiti Zuraidah Mohamad Zobir
Siti Zuraidah Mohamad Zobir
FFFazlin Mohd Fauzi
Fazlin Mohd Fauzi
SLSonia Liggi
Sonia Liggi
GDGeorgios Drakakis
Georgios Drakakis
XFXianjun Fu
Xianjun Fu
ABAndreas Bender
Andreas Bender
Traditional Chinese medicine (TCM) still needs more scientific rationale to be proven for it to be accepted further in the West. We are now in the position to propose computational hypotheses for the mode‐of‐actions (MOAs) of 45 TCM therapeutic action (sub)classes from in silico target prediction algorithms, whose target was later annotated with Kyoto Encyclopedia of Genes and Genomes pathway, and to discover the relationship between them by generating a hierarchical clustering. The results of 10,749 TCM compounds showed 183 enriched targets and 99 enriched pathways from Estimation Score ≤ 0 and ≥ 5% of compounds/targets in a (sub)class. The MOA of a (sub)class was established from supporting literature. Overall, the most frequent top three enriched targets/pathways were immune‐related targets such as tyrosine‐protein phosphatase nonreceptor type 2 (PTPN2) and digestive system such as mineral absorption. We found two major protein families, G‐protein coupled receptor (GPCR), and protein kinase family contributed to the diversity of the bioactivity space, while digestive system was consistently annotated pathway motif, which agreed with the important treatment principle of TCM, “the foundation of acquired constitution” that includes spleen and stomach. In short, the TCM (sub)classes, in many cases share similar targets/pathways despite having different indications.